Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 2;92(14):e1643-e1651.
doi: 10.1212/WNL.0000000000007244. Epub 2019 Mar 8.

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial

Andrew McGarry  1 , Michael P McDermott  2 , Karl Kieburtz  2 , Wai Lun Alan Fung  2 , Elizabeth McCusker  2 , Jing Peng  2 , Elisabeth A de Blieck  2 , Merit Cudkowicz  2 ; Huntington Study Group 2CARE Investigators and Coordinators
Collaborators, Affiliations

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial

Andrew McGarry et al. Neurology. .

Abstract

Objective: Most suicidality literature in Huntington disease (HD) is based on natural history studies or retrospective reviews, but reports on risk factors from clinical trials are limited.

Methods: We analyzed 609 participants from 2CARE, a randomized, double-blind, placebo-controlled clinical trial with up to 5 years of follow-up, for risk factors related to suicidality. The primary outcome variable was the time from randomization until the first occurrence of either suicidal ideation or attempt. We also considered time from randomization until the first suicide attempt as a secondary outcome variable.

Results: Depression, anxiety, bipolar disorder, antidepressant or anxiolytic use, and prior suicide attempt at baseline were associated with time to ideation or attempt. Baseline employment status, marital status, CAG repeat length, tetrabenazine use, and treatment assignment (coenzyme Q10 or placebo) were not associated with suicidality. Time-dependent variables from the Unified Huntington's Disease Rating Scale Behavioral Assessment were associated with time to suicidal ideation or attempt, driven mainly by items related to depressed mood, low self-esteem/guilt, anxiety, suicidal thoughts, irritability, and compulsions. Variables associated with time to suicide attempt alone were generally similar.

Conclusion: These data suggest psychiatric comorbidities in HD are predictive of suicidal behavior while participating in clinical trials, reinforcing the importance of clinical surveillance and treatment towards lessening risk during participation and perhaps beyond. Designing a composite algorithm for early prediction of suicide attempts in HD may be of value, particularly given anticipated trials aimed at disease modification are likely to be long-term.

Clinicaltrialsgov identifier: NCT00608881.

PubMed Disclaimer

Figures

Figure
Figure. Kaplan-Meier estimate of the cumulative distribution of time to suicidal ideation/attempt by active psychiatric diagnosis at baseline
See this image and copyright information in PMC

Comment in

References

    1. van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441–448. - PubMed
    1. Orth M, Handley OJ, Schwenke C, et al. . Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. PLoS Currents 2011;2:RRN1184. - PMC - PubMed
    1. Paulsen JS, Hoth KF, Nehl C, Stierman L. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry 2005;162:725–731. - PubMed
    1. Stierman A, McDermott M, Kieburtz K, et al. . A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 2017;88:152–159. - PMC - PubMed
    1. Huntington Study Group. The Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136–142. - PubMed

Publication types

MeSH terms

Associated data